Literature DB >> 18695591

What belgian neurologists and neuropsychiatrists tell their patients with Alzheimer disease and why: a national survey.

Meriem Essabiri Tarek1, Kurt Segers, Christian Van Nechel.   

Abstract

To check their opinions concerning the disclosure of the diagnosis of Alzheimer disease (AD), a questionnaire was sent to all neurologists and neuropsychiatrists currently active in Belgium, excluding neuropediatricians. Of 573 questionnaires, 44% were returned. Sixty-eight percent of the responders always announce the diagnosis to their patients, 24% prefer to reveal the diagnosis only to patients with mild dementia. Doctors who announce the diagnosis to all their patients and who believe that its a benefit for the patient (67%) were more likely to be younger, to be neurologists, and to speak Dutch. The most important arguments in favor of announcing the diagnosis were the patient's right to know and the reinforcement of the doctor-patient relationship. The main arguments against revealing the diagnosis were the patient's right not to know and fear of provoking a depression. Two-third of the participants informed the patients about the prognosis and natural evolution of AD. These doctors tended to be younger, to be neurologists, and to speak Dutch. Young doctors tend to be more "open" toward their patients concerning the diagnosis of AD, consistent with the current guidelines. The differences between Dutch and French speaking doctors might be partially due to the fact that in French, "démence" has a psychiatric connotation.

Entities:  

Mesh:

Year:  2009        PMID: 18695591     DOI: 10.1097/WAD.0b013e31817d5e4c

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  3 in total

1.  Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.

Authors:  John C Morris
Journal:  Arch Neurol       Date:  2012-06

2.  Clinicians' views on conversations and shared decision making in diagnostic testing for Alzheimer's disease: The ABIDE project.

Authors:  Marleen Kunneman; Ellen M A Smets; Femke H Bouwman; Niki S M Schoonenboom; Marissa D Zwan; Ruth Pel-Littel; Wiesje M van der Flier
Journal:  Alzheimers Dement (N Y)       Date:  2017-05-10

3.  General practitioner's clinical practices, difficulties and educational needs to manage Alzheimer's disease in France: analysis of national telephone-inquiry data.

Authors:  Dominique Somme; Arnaud Gautier; Stéphanie Pin; Aline Corvol
Journal:  BMC Fam Pract       Date:  2013-06-13       Impact factor: 2.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.